2,193
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation

, &
Pages 815-826 | Received 08 Feb 2018, Accepted 08 Mar 2018, Published online: 20 Mar 2018

References

  • Abdallah MH. (2013). Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of nystatin. Int J Pharm Pharm Sci 5:560–7.
  • Abdelbary AA, AbouGhaly MH. (2015). Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 485:235–43.
  • Abdelbary GA, Aburahma MH. (2015). Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. J Liposome Res 25:107–21.
  • Ahad A, Al-Jenoobi FI, Al-Mohizea AM, et al. (2013). Transdermal delivery of calcium channel blockers for hypertension. Expert Opin Drug Deliv 10:1137–53.
  • Al-Mahallawi AM, Abdelbary AA, Aburahma MH. (2015). Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm 485:329–40.
  • Al-Mahallawi AM, Khowessah OM, Shoukri RA. (2014). Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm 472:304–14.
  • Auda SH, Fathalla D, Fetih G, et al. (2016). Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies. Polym Bull 73:1229–45.
  • Aziz DE, Abdelbary AA, Elassasy AI. (2018). Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study. J Liposome Res 1–13. DOI: 10.1080/08982104.2018.1430831
  • Bancroft JD, Gamble M. (2008). Theory and practice of histological techniques. 6th ed. Philadelphia (PA): Churchill Livingstone/Elsevier.
  • Bhowmik D, Chiranjib CM, Jayakar B, et al. (2010). Recent advances in transdermal drug delivery system. Int J Pharm Tech Res 2:68–77.
  • Cevc G, Blume G. (2003). Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersomes. Biochim Biophys Acta 1614:156–64.
  • Dai Y, Zhou R, Liu L, et al. (2013). Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine 8:1921–33.
  • De Lima LS, Araujo MDM, Quináia SP, et al. (2011). Adsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial design. Chem Eng J 166:881–9.
  • DeLoach R, Ulbrich N. (2007). A comparison of two balance calibration model building methods. 45th AIAA Aerospace Sciences Meeting and Exhibit, held at Reno, Nevada, 8–11.
  • Dhaneshwar S, Patel V, Patil D, et al. (2013). Studies on synthesis, stability, release and pharmacodynamic profile of a novel diacerein-thymol prodrug. Bioorg Med Chem Lett 23:55–61.
  • Duangjit S, Opanasopit P, Rojanarata T, et al. (2013). Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers. AAPS PharmSciTech 14:133–40.
  • Duangjit S, Pamornpathomkul B, Opanasopit P, et al. (2014). Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes. Int J Nanomedicine 9:2005.
  • El-Laithy HM, Basalious EB, El-Hoseiny BM, et al. (2015). Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: Simultaneous portal blood absorption and lymphatic delivery. Int J Pharm 490:146–54.
  • El-Say KM, Abd-Allah FI, Lila AE, et al. (2016). Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. J Liposome Res 26:57–68.
  • El Zaafarany GM, Awad GA, Holayel SM, et al. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–72.
  • Elsayed I, Abdelbary AA, Elshafeey AH. (2014). Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. Int J Nanomedicine 9:2943–53.
  • Fahmy UA. (2015). Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation. Drug Des Devel Ther 9:6129–37.
  • Gupta PN, Mishra V, Rawat A, et al. (2005). Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 293:73–82.
  • Hao Y, Zhao F, Li N, et al. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80.
  • Jain A, Singh SK, Singh Y, et al. (2013). Development of lipid nanoparticles of diacerein, an antiosteoarthritic drug for enhancement in bioavailability and reduction in its side effects. J Biomed Nanotechnol 9:891–900.
  • Kakkar S, Kaur IP. (2011). Spanlastics-A novel nanovesicular carrier system for ocular delivery. Int J Pharm 413:202–10.
  • Kakkar S, Kaur IP. (2013). A novel nanovesicular carrier system to deliver drug topically. Pharm Dev Technol 18:673–85.
  • Khan MI, Madni A, Ahmad S, et al. (2015). Formulation design and characterization of a non-ionic surfactant based vesicular system for the sustained delivery of a new chondroprotective agent. Braz J Pharm Sci 51:607–15.
  • Lake OA, Olling M, Barends DM. (1999). In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Eur J Pharm Biopharm 48:13–9.
  • Lei W, Yu C, Lin H, et al. (2013). Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo. AJPS 8:336–45.
  • Ma M, Wang J, Guo F, et al. (2015). Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation. J Mater Sci Mater Med 26:191
  • Medhi B, Singh PS, Prakash A. (2007). Diacerein: a new disease modulating agent in osteoarthritis. IJPMR 18:48–52.
  • Moghddam SR, Ahad A, Aqil M, et al. (2016). Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mater Sci Eng C Mater Biol Appl 69:789–97.
  • Mohammed A, Weston N, Coombes A, et al. (2004). Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 285:23–34.
  • Muzzalupo R, Tavano L, Cassano R, et al. (2011). A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eur J Pharm Biopharm 79:28–35.
  • Peira E, Trotta M, Carlotti M, et al. (2007). Elastic positively-charged liposomes for topical administration of acyclovir. J Drug Deliv Sci Technol 17:321–4.
  • Rao J, Chauhan K, Mahadik KR, et al. (2009). A stability-indicating high performance liquid chromatographic method for the determination of diacerein in capsules. Indian J Pharm Sci 71:24–9.
  • Rudra A, Deepa RM, Ghosh MK, et al. (2010). Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats. Int J Nanomedicine 5:811–23.
  • Salama HA, Mahmoud AA, Kamel AO, et al. (2012). Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. J Liposome Res 22:336–45.
  • Shen LN, Zhang YT, Wang Q, et al. (2014). Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm 460:280–8.
  • Som I, Bhatia K, Yasir M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci 4:2–9.
  • Tadros MI, Al-Mahallawi AM. (2015). Long-circulating lipoprotein-mimic nanoparticles for smart intravenous delivery of a practically-insoluble antineoplastic drug: development, preliminary safety evaluations and preclinical pharmacokinetic studies. Int J Pharm 493:439–50.
  • Tamizharasi S, Dubey A, Rathi V, et al. (2009). Development and characterization of niosomal drug delivery of gliclazide. J Young Pharmacists 1:205.
  • Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes – novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403–18.
  • Trivedi MK, Patil S, Mishra RK, et al. (2015). Thermal and physical properties of biofield treated bile salt and proteose peptone. J Anal Bioanal Tech 6:256.
  • Van Den Bergh BA, Wertz PW, Junginger HE, et al. (2001). Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 217:13–24.
  • Verbruggen G. (2006). Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford) 45:129–38.
  • Volpato NM, Silva RL, Brito APP, et al. (2004). Multiple level C in vitro/in vivo correlation of dissolution profiles of two l-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. Eur J Pharm Sci 21:655–60.
  • Walve J, Bakliwal S, Rane B, et al. (2011). Transfersomes: a surrogated carrier for transdermal drug delivery system. Int J Appl Bio Pharm Technol 2:204–13.
  • Wilson B, Samanta MK, Santhi K, et al. (2008). Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer’s disease. Brain Res 1200:159–68.